Immunant Competitors

Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease.

We envision a world where our technology is amplified to touch the lives of billions, sparking transformation in global health.

Tessera Therapeutics is a biotechnology company pioneering a new approach to genome engineering through the development of its Gene Writing™ and delivery platforms, with the aim to unlock broad new therapeutic frontiers. Our mission is to cure disease by writing in the code of life. We believe our Gene Writing™ and delivery platforms will enable transformative genetic medicines to treat monogenic diseases, cancer and potentially autoimmune and other diseases. Discover your future at Tessera.